EcoDrugPlus

Ensembl ID : HMEL011995
Gene Symbol: -
External references: -
258 Possible Orthologues:

Ensembl ID : HMEL012004
Gene Symbol: -
External references: -
260 Possible Orthologues:

Ensembl ID : HMEL012075
Gene Symbol: -
External references: -
40 Possible Orthologues:

Ensembl ID : HMEL012111
Gene Symbol: -
External references: -
209 Possible Orthologues:

Ensembl ID : HMEL012150
Gene Symbol: -
External references: -
263 Possible Orthologues:

Ensembl ID : HMEL012154
Gene Symbol: -
External references: -
363 Possible Orthologues:

Ensembl ID : HMEL012235
Gene Symbol: -
External references: -
78 Possible Orthologues:

Ensembl ID : HMEL012244
Gene Symbol: -
External references: -
150 Possible Orthologues:

Ensembl ID : HMEL012250
Gene Symbol: -
External references: -
1438 Possible Orthologues:

Ensembl ID : HMEL012265
Gene Symbol: -
External references: -
340 Possible Orthologues:

Ensembl ID : HMEL012282
Gene Symbol: -
External references: -
541 Possible Orthologues:

Ensembl ID : HMEL012308
Gene Symbol: -
External references: -
147 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).